FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of InteRNA Technologies

InteRNA Technologies announces establishment of Scientific Advisory Board

09-Jul-2010 - InteRNA Technologies B.V. announced the establishment of its Scientific Advisory Board (SAB). The SAB will further guide the Company in the development of cancer therapies based on the unique functions of its proprietary miRNAs. The SAB is chaired by Emile E. Voest, MD, PhD, Professor of Medical ...

biology Formation genetics +4

InteRNA Technologies and Dana-Farber Cancer Institute to collaborate on the role of microRNAs in cancer pathways

03-Nov-2009 - InteRNA Technologies B.V. and the Dana-Farber Cancer Institute have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for cancer. Under the research collaboration with Associate Professor William C. Hahn, MD, PhD (Department of Medical Oncology), InteRNA’s ...

cell-based assays microRNAs oncology +2

InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer

24-Apr-2009 - InteRNA Technologies B.V. and Radboud University Nijmegen Medical Centre have entered into a research agreement to develop microRNA (miRNA)-based therapeutics for prostate cancer. Under the research collaboration with professor Jack Schalken (Laboratory of Experimental Urology), InteRNA’s unique ...

cell-based assays microRNAs prostate cancer +3

InteRNA Technologies and VU University Medical Center to Develop microRNA-based Diagnostics and Therapeutics for Cancer

03-Nov-2008 - InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announced the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA’s proprietary library of miRNAs. Under the research collaboration, ...

diagnostics leukemia neck cancer +5